SOCS3 and small cell lung carcinoma: SOCS3 has been observed during angiogenesis as a negative regulator from studies of both human small cell lung cancer and colorectal cancers, while dysregulation of SOCS3 gene expression has been associated with both CAD and related conditions including acute coronary syndrome85–88.